<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Issue Brief</title>
    <link>https://policyresearch.jnj.com/issue-brief</link>
    <description>Issue Brief</description>
    <language>en-US</language>
    <lastBuildDate>Mon, 11 May 2026 20:43:58 GMT</lastBuildDate>
    <atom:link href="https://policyresearch.jnj.com/issue-brief.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Full text: The value of medicines in the U.S.</title>
      <link>https://policyresearch.jnj.com/full-text-the-value-of-medicines-in-the-u-s</link>
      <description>Johnson &amp;amp; Johnson Issue Brief</description>
      <pubDate>Mon, 11 May 2026 20:43:58 GMT</pubDate>
      <guid>https://policyresearch.jnj.com/full-text-the-value-of-medicines-in-the-u-s</guid>
    </item>
    <item>
      <title>The 340B Program: Issue brief</title>
      <link>https://policyresearch.jnj.com/transparency/the-340b-program</link>
      <description>How arbitrage, opportunism and opacity undermine the Program’s original purpose</description>
      <pubDate>Sat, 01 Jan 2022 22:15:17 GMT</pubDate>
      <guid>https://policyresearch.jnj.com/transparency/the-340b-program</guid>
    </item>
  </channel>
</rss>
